chrisvoncsefalvay/vaers-outcomes huggingface dataset:
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/21/220 2nd dose01/11/2021 Diagnosed covid positive:09/08/21 Symptom onset:09.08.21 Exposure:community Symptoms:Asymptomatic
After I received my second dose of Moderna Vaccine 3/25/21, I had a reoccurrence of Shingles (4/11/21). I believe this was a reaction to the moderna Covid vaccine
This case was reported by a healthcare profession and described the occurrence of injection site pain in a subject of unknown age and gender who was vaccinated with Flulaval for prophylaxis. On an unspecified date on or prior to 05 February 2007, the subject received an unspecified dose of Flulaval. At an unspecified time after vaccination with Flulaval, the subject experienced severe pain at injection site, nausea, fever, aches and pain, and pharmaceutical product compliant. The reporter indicated that there were approximately six other patients who received the same lot of Flulaval who experienced the same adverse events. The reporter requested a credit for the remaining 86 Flulaval vials he had in stock, which were from the same lot. At the time of reporting the outcome of the events were was unspecified.
pt recvd vax; pt devel fever up to 104; vomiting; red & tender in inject site, delirious during night;
10 hours after second dose: headache, chills, body aches, and muscle soreness.   20 hours after second dose: all previous symptoms, in addition to low-grade fever, nausea, and vomiting.
Systemic: Confusion-Mild, Systemic: Fainting / Unresponsive-Medium, Additional Details: VS X 3-  1st BP 122/90, HR 100, RR 20, SATS 98% RA; 2nd bp126/92, hr 81, RR 18, O2 SATs 98 RA; 3rd BP130/82, HR 80, RR 20, O2 SATs 98% RA. delayed syncope episode < 5 minutes after IM injection, reported dream-like feeling before fainting, confusioned but recovered quickly.
11-5-12 - Rec vaccine. 11-8-12 - Started hurting (swollen & red). 11-14-12 - To ER - Dx with (R) arm cellulitis & infection at injection site, Rx pain meds and antibiotics prescribed by ER doctor.
Client had MENACTRA & HPV #3 on 5/11/11. The next day at 2 A.M. patient had fever, severe chills & then profusive sweating, dizziness, headache & weakness. (Had lighter, similar reaction when she had #2 HPV).
Flu shot approx. 11:03. Patient returned approximately 11:35 complaint of fever. Slight hot to touch. Took BP 152/89, later 132/88. Patient walked along highway on own without assistance. Not dizzy. Gait fine. No rash. No breathing issues, normal color.
Information has been received from an other health professional concerning a female patient who on an unspecified date, was vaccinated with a dose of PNEUMOVAX 23 (lot# not reported). It was reported that on an unspecified date, the patient experienced soreness and swelling. At the time of the report, the patient's outcome was unknown. It was unknown if the patient sought medical attention. This is one of several reports received from the same resource. No further information is available.
No additional adverse event; The patient was inadertently administered a dose of PROQUAD, that had been improperly stored; This spontaneous report was received from a nurse concerning to a 4-year-old patient of unknown gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, or drug reactions/allergies.    On 05-JUN-2020, there was previous temperature excursion of 6 Fahrenheit degrees to 14 Fahrenheit degrees  for 1 hour; 15 Fahrenheit degrees to 46 Fahrenheit degrees  for 4 hours. On 08-JUN-2020, 6 Fahrenheit degrees  to 14 Fahrenheit degrees  for 1 hour and 50 minutes and on 15-JUN-2020, 6 Fahrenheit degrees  to 14 Fahrenheit degrees  for 20 minutes.   On 16-JUN-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) injection, lot # S030215 expiration date not reported, but upon internal validation established as 25-MAR-2021, for prophylaxis (strength, dose schedule, anatomical site of injection and route of administration were not reported) (product storage error). The sterile diluent was properly stored.  The administered dose of the vaccine experienced a temperature of 7.2 Fahrenheit degrees  for 30 minutes recorded by a data logger. There was no additional adverse event reported.
Systemic: Abdominal Pain-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Mild, Systemic: Fever-Medium, Systemic: Headache-Severe, Systemic: Nausea-Severe, Additional Details: Patient was vaccinated 7/18 and called on 7/23. Patient has had side effects of uncontrollable headache/migraines, muscle aches, general pain, periodic chills, night time fever, & nausea/vomitting (has not been ablel to keep food down). Symptoms have not gone away or gotten better
Pt recv vax on 9/2/98; on 9/3/98 pt exp fever for 5 day (102F) spiking to 104.5-104.8; tx=Tylenol every 4-6hr
Lightheadedness, couldn't think straight, nausea, joint aches, severe shaking, shivers, very cold, then hot (but no fever), headache.
Vomiting; Dehydration; Chest pain; Throat irritation; This is a spontaneous report received from a contactable consumer (patient).  A 32-years-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 31Mar2021 19:30 (Lot number Er87277121) as DOSE 1, SINGLE (age at vaccination 32 years old) for covid-19 immunization. Medical history included known allergies: Penicillin from an unknown date and unknown if ongoing. There were no concomitant medications.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 31Mar2021 21:30, the patient experienced vomiting. In 2021 the patient experienced dehydration, chest pain and throat irritation.The patient experienced continuous vomiting which began approximately 2 hours after receiving injection. It has now been 72 hours. Vomiting has not stopped. Vomiting causing chest pain and throat irritation. Patient needed to go to Urgent care for dehydration. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has been tested for COVID-19The patient underwent lab tests and procedures which included Covid test post vaccination Nasal Swab: negative on 02Apr2021. Therapeutic measures were taken as a result of dehydration which included intravenous (IV drip). Outcome of the events were not recovered.
Child had swelling,redness,and heat around area of shotDTAP .Signs persisted and mother took child to E.R. There he received an antibiotic and generic Benedryl .This ocurred 2 days after the shot.
Said to have suffered multiple strokes; While in Germany was hospitalized unable use her left side; Can't grip or grab anything with left hand, limping when walking; Can't grip or grab anything with left hand, limping when walking; This is a spontaneous report from a non-contactable consumer or other non-health care professional (patient). An unspecified age (pregnant-unknown) female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number and Expiration date was not reported), via an intramuscular route of administration on an unspecified date Jul2021, as  dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had experienced said to have suffered multiple strokes and was hospitalized unable use her left side, can't grip or grab anything with left hand, and limping when walking. On an unspecified date, the patient underwent lab tests and procedures which included grip or grab, Grip strength: Can't grip or grab anything with left hand, can't grip or grab anything with left hand, limping when walking; and Magnetic resonance imaging: Unknown results. Caller stated, adverse events resulted in hospitalization. The outcome for all the vents was unknown.  Follow-up (22Jul2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported in response to the Non-HCP letter via email follow up that included: I have no further details than what was provided in the initial report.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
3-4cm Wheal formation (raised, warm erythema) x 14 days
This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received KINRIX (batch number 43HB3, expiry date 19th May 2018). In August 2016, the patient received KINRIX .5 ml. In August 2016, an unknown time after receiving KINRIX, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional details were provided as follows: The patient received a dose of KINRIX at an age of 4 months, which led to an inappropriate age at vaccine administration. No side effects were reported. Follow up information was received from other health professional on 17th October 2016: The reporter's contact details were updated. It was reported that the dose of KINRIX was given in the office. The medication was combo in which the patient needed both the vaccines, but did not realize that the medication was for specific age group. The patient's mother was called and she advised that the patient had local reaction (injection site reaction) that lasted for 1 day and otherwise doing well. The patient's mother talked with GlaxoSmithKline and was advised that amount of vaccines (each present in combo) would be the same as if given separately (not in combo vaccine). The VAERS details were updated.
Child given 4th dose of IPV at shot appointment.  Child did not need this dose of vaccine.
Feeling unwell; Temperature 38C/Temperature 38.4C; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling unwell) and PYREXIA (Temperature 38C/Temperature 38.4C) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced MALAISE (Feeling unwell) and PYREXIA (Temperature 38C/Temperature 38.4C). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form and PARACETAMOL ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, MALAISE (Feeling unwell) and PYREXIA (Temperature 38C/Temperature 38.4C) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Body temperature: 38, 38.4 (High) 38, 38.4.         No concomitant medication has been reported. Action taken with mRNA-1273 in response to the events was not applicable.
Began with vomiting and diarrhea. C/O chest pain. Bradycardia. Hypotension.  2 seizures in 45 minutes after not having one in years.  We gave fluids. Gave Zofran. Comfort measures.  Pt passed at midnight. Was completely fine one day before. Had minimal issues with COVID though did have a pneumonia that was treated w ATB early on and resolved.
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 01/21/2021 and 02/18/2021. They tested positive for COVID-19 via antigen test on 09/23/2021 at the nursing home at which they were a resident. They presented to emergency department on 09/23/2021 for purposes of receiving BAM-E treatment for the COVID-19 infection and were admitted same-day. Tachycardia was noted upon admission. The individual received the BAM-E treatment seemingly without complications. It was noted the individual was retaining urine and telemetry showed A-Fib. They were discharged back to nursing home on 09/27/2021. The individual died on 09/30/2021.
p/1hr severe h/a pt phoned PHN @ 425PM 28OCT96;referred to pvt MD;sent to ER for CAT scan & spinal tap;neg for spinal meningitis;office visit 29OCT96 w/MD rx for med;
Heart pains, difficult to move at times, lots of pressure in the chest.  Heart would get locked in a spasm. Shortness of breath. Palpitations. Racing mind.
Injection given Wednesday 4/27/22. Thursday 4/28/22 light flu type symptoms. Body ache all over. Spent most of day sleeping or resting took tylenol for discomfort . Friday 4/29/22 3:45 AM felt heart issue. Checked twice with Watch EKG. Indicated Atrial fibrillation. Drove to hospital, EKG confirmed Atrial Fibrillation. Received two medications, heart rhythm returned to normal. Sent home with heart monitor.
pt left premises and made a u-turn returned to facility c/o itching in nose and airway redness noted in throat no swelling noted O2@100% HR 72 Bil Lung sounds clear to auscultation 122/76 B/P  Resp: 20 Benadryl 25 mg po administered  remained with pt for additional 30 min. symptoms resolved and pt left premises to return home followed up with pt via text 30 min later pt is safely home denies any further symptoms or concerns
red spots on the injection arm at the injection site; Itchy at injection site; Rash at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (red spots on the injection arm at the injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE RASH (Rash at injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A84A) for COVID-19 vaccination.     Concurrent medical conditions included Mastocytosis and Acid reflux (esophageal). Concomitant products included VITAMINS NOS for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red spots on the injection arm at the injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE RASH (Rash at injection site). The patient was treated with PREDNISONE at a dose of 14 mg; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (red spots on the injection arm at the injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE RASH (Rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications provided were acid reflux medication. Treatment medications provided were topical ointment, Antihistamines and Ice.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up information received on 10-May-2021 contain no new information.
This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (each time soreness at the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced VACCINATION SITE PAIN (each time soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (each time soreness at the injection site) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No allergies were reported. Patient was never had COVID positive test or diagnosis. No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine. No relevant concomitant medications were reported. Treatment medication was not provided by the reporter. This case was linked to MOD-2022-545276, MOD-2022-545277, MOD-2022-545265 (Patient Link).
PATIENT RETURNED TO CLINIC THE DAY AFTER THE INJECTION OF PCV13 IN RIGHT DELTOID WITH COMPLAINTS OF ITCHING AT SITE, DENIAL OF PAIN, MINIMAL SWELLING, MINIMAL HEAT AT INJECTION SITE AND REDNESS DOWN TO RIGHT ELBOW AND UNDER ARM. PATIENT INFORMED BY DR. THAT IT WAS AN ALLERGIC REACTION AND PATIENT WAS GIVEN INSTRUCTIONS ON ADMINISTERING BENADRYL BASED ON HIS WEIGHT. PATIENT RETURNED TO CLINIC 8/16/10 WITH COMPLAINTS OF FINGER TIPS PEELING, HOWEVER, AFTER BEING EXAMINED BY THE DOCTOR, HE ALSO HAD A "STRAWBERRY COLORED" TONGUE. DR. EXPLAINED THIS WAS NOT RELATED TO THE VACCINE, THIS WAS RELATED TO THE STREP DIAGNOSIS ON 8/5/10 AND HE WAS PRESCRIBED ANOTHER ANTIBIOTIC.  PATIENT'S ARM HAD COMPLETELY RESOLVED WITH NO FURTHER COMPLAINTS.
Fever, joint and muscle pain (entire body), nausea, headache, cough; all symptoms lasted about 12 hrs. Treated with Advil.
pt recvd vax;grandma said pt had high pitched cry;legs swollen & very red;to er;was tx at noc & taken back in the am & adm to hosp;
pt recvd vax & mom states pt vomited 4 times p/receiving vax, pulse 168, t98.8 auricle;
Since receiving the first dose of the Moderna until the present day, and yet unresolved, I have suffered daily headaches, bladder infections,  lethargy, and periodic muscle aches.
PATIENT ADMITTED TO HOSPITAL ON 7/9/22 FROM OUTSIDE FACILITY FOR AN AKI ON TOP OF HER CKD. SHE WAS COVID-19+ AT TIME OF ADMISSION AND REQUIRING OXYGEN. PATIENT HAD RECURRENT STROKES, GI BLEED, AND ACUTE ON CKD. PATIENT DECLINED DURING ADMISSION AND WAS TRANSITIONED TO DNR/DNI AND THEN MADE COMFORTABLE. PATIENT DIED 8/2/2022.
C/O generalized rash, sore throat, pain and swelling of neck. c/o headache, and ear pain as well.
Very enlarged, squishy, painful lymph node above left collarbone Sore left arm Fatigue, nausea
A week after receiving a J&J booster shot, I developed severe sinus pressure and congestion. I was diagnosed with a sinus infection and took a 7 day antibiotic. I have year round allergies and constant sinus pressure and issues. Occasionally I have sinus infections. This is normal for me so I don't believe it had anything to do with the vaccination.
After getting the shot I had a medicine taste in my mouth. About 10 min after getting the shot I had gotten dizzy. felt dizzy for about 30 minutes.
right sided tingling at corner of lip up towards top of eye approx 10 min post shot
Patient came in today to receive a COVD-19 vaccine. When asked for their vaccination card, they stated it was their first dose. When the patient's name and DOB was searched in immunization registry no account resulted. A full moderna dose (0.5ml) was administered. When attempting to add the patient to immunization registry, an account was found. Immunization registry indicated the patient had a pervious dose of Janssen.
p/vax pt 7/29/99 MOC called office describing a strange grunting cry p/finishing breastfeeding;MOC picked child up & seemed stiff, eyes were rolled back & seemed unresponsive;no tonic clonic activity;exam nl x/sl dec tonic;nl wake/drowsy;
I?ve always had eczema, but after the vaccine it became MUCH MUCH worse. It?s so bad. Both of my eyes look like someone punched them. My neck and chin are red as well and some on my arms. It?s so painful, it keeps me awake at night. It?s the worst it?s ever been in my life.
got the vaccine and then got shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient got the Shingles vaccine and then got shingles three times within the next two years. The patient also had a bad reaction to the vaccine. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting.
Vaccine Dose 1 12/17/2020: I received the vaccine and within 5 minutes I experienced dizziness, sweating and was flushed. After 15 minutes the dizziness did not go away and my vitals were checked. My BP was elevated 136/106 and HR 105, I was taken to the ED after repeated BP readings continued to show increased diastolic pressure. I was observed in ED for a period of almost 6 hours. Within an 1.5 hours after receiving vaccine, I had right neck stiffness, headache, and some weakness to the right side as well along with the dizziness and high BP. I received a 1L bolus of NS, 2 doses of antivert, Toradol, Zofran and Lidocaine patches. 24 hours after receiving vaccines, I was having pain at the insertion site, headache, neck stiffness and occasional dizziness. After 36 hours my symptoms subsided and I felt back to baseline.   Vaccine Dose 2 01/07/2020: I received my second dose of the COVID vaccine and within the first 15 minutes I experienced dizziness, nausea, flashing spots in vision, right sided weakness, increased BP & HR, redness and sweating. After 30 minutes the symptoms did not subsided and I was taken to the ED. An hour after receiving the vaccine, I had right sided weakness to arm and legs with no numbness, dizziness, R. sided neck stiffness, right sided headache, nausea and flashing spots. I received Ativan, Reglan, Tylenol, Toradol and Benadryl in the ED. I was in ED for 3.5 hours after vaccines was administered and was able to ambulate to the car independently.   16 hours after receiving vaccine, I had muscle weakness to bilateral lower extremities and was unable to ambulate independently along with dizziness, headache, arm soreness, cough, congestion, neck stiffness and fatigue. 36 hours after vaccine I regained movement to bilateral lower extremities however still was experiencing fatigue, occasional dizziness, intermittent neck stiffness and headache, body aches and some shakiness to lower extremities. 55 hours after receiving vaccine I was still fatigued and experiencing intermittent headache and neck stiffness. 72 hours after vaccine I was still fatigued and having occasional headaches but feeling much much better from initial reaction. 96 hours after receiving vaccine I experienced occasional headache, woke up with neck stiffness and was finally able to drive a car without any dizziness or nausea. 144 hours after vaccine I am not completely back to baseline still fatigued with occasional neck stiffness and headache but able to go back to work.
Almost immediately after the first shot, I felt joint pain in my knees. It was mild. and went away. After the second shot it came back and has never left. The pain sometimes makes it difficult kneel down and stand up. On 4/25/2022 I went to the emergency room with pains in my chest. They found fluid in my lungs. This has never happened to me before. They gave me a steroid on arrival and that temporarily fixed my knee pain for about a week.